Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 25.06.2024
Edison Investment Research Limited
London, UK, 25 Juni 2024
Edison issues report on Metlen Energy & Metals (MYTIL)
Click here to view the full report.
All reports published by Edison are available to download free of charge from its website
www.edisongroup.com
Edison is authorised and regulated by the Financial Conduct Authority.
Edison is not an adviser or broker-de [ … ]
Tue, 25.06.2024
Branicks Group AG
Press release
Branicks Group AG: New and follow-up lettings in Frankfurt's trade fair and banking district
Letting of 6,500 square metres of office space to tenants from the financial sector
Sustainability certificates and property quality strong criteria for tenants
Clear trend towards back to office
Frankfurt am Main, 25 June 2024: B [ … ]
Tue, 25.06.2024
C-QUADRAT Investment AG
EQS-Media / 25.06.2024 / 09:08 CET/CEST
Assets under Management in excess of EUR 9 billion
ARTS Asset Management GmbH shareholding successfully increased from 45 to 55%
Fundraising for AMC V ends with record capital commitments
Vienna, 25 June 2024 – The first half of 2024 was characterised by dynamic growth in assets under management, an [ … ]
Tue, 25.06.2024
clearvise AG
clearvise AG realizes two more solar parks through cooperation in Italy
Solar parks with a total capacity of 14.2 MWp planned on former quarries
Approval procedure underway at neighboring sites south of Rome
Start of construction and commissioning of the solar parks expected in 2025
Frankfurt, 25 June 2024 – clearvise AG (WKN A1EWXA / ISIN DE000 [ … ]
Tue, 25.06.2024
Defence Therapeutics Inc.
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
Vancouver, BC, Canada, June 25th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation ARM-X anti-cancer vaccine is therap [ … ]
Tue, 25.06.2024
Defence Therapeutics Inc.
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
Vancouver, BC, Canada, June 25th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation ARM-X anti-cancer vaccine is therap [ … ]
Tue, 25.06.2024
Evotec SE
Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s Manufacturing Optimization Program
Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimization Program
Manufacturing Optimization P [ … ]
Tue, 25.06.2024
HORNBACH Holding AG & Co. KGaA
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
Consolidated net sales increased by 1.8% in Q1 2024/25 due to favorable weather conditions counterbalancing effects of the ongoing challenging consumer environment
Adjusted consolidated operating earnings (EBIT) inc [ … ]
Tue, 25.06.2024
HORNBACH Holding AG & Co. KGaA
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
Consolidated net sales increased by 1.8% in Q1 2024/25 due to favorable weather conditions counterbalancing effects of the ongoing challenging consumer environment
Adjusted consolidated operating earnings (EBIT) inc [ … ]
Tue, 25.06.2024
Kuros Biosciences AG
Kuros Biosciences AG
/ Key word(s): Study results/Scientific publication
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft 25.06.2024 / 07:00 CET/CEST
Schlieren (Zurich), Switzerland, June 25, 2024 – Kuros Biosciences, a leader in next [ … ]